Jonathan Graham, EVP and General Counsel and Secretary at Amgen, shared on LinkedIn:
“We are delighted to see that Amgen has been named to The Wall Street Journal’s inaugural 2026 Best Companies for the Future list.
Our company has been at the forefront of biotech for 45+ years and has every intention of staying there.
This recognition reflects that external observers see what the strength of our team and our focus on cutting-edge innovation and technology can mean for the patients of the future.
Thank you to our colleagues around the world who make this type of recognition possible.
Read more: Amgen Named to The Wall Street Journal’s Inaugural 2026 Best Companies for the Future List Amgen Named to The Wall Street Journal’s Inaugural 2026 Best Companies for the Future List.”
Other articles about Amgen on OncoDaily.